摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-bromo-7,8-dimethoxy-3-[4-(2-methyl-3-phenylallyl)piperazin-1-ylmethyl]-3a,4-dihydro-3H-chromeno[4,3-c]isoxazole

中文名称
——
中文别名
——
英文名称
6-bromo-7,8-dimethoxy-3-[4-(2-methyl-3-phenylallyl)piperazin-1-ylmethyl]-3a,4-dihydro-3H-chromeno[4,3-c]isoxazole
英文别名
6-bromo-7,8-dimethoxy-3-[[4-[(E)-2-methyl-3-phenylprop-2-enyl]piperazin-1-yl]methyl]-3a,4-dihydro-3H-chromeno[4,3-c][1,2]oxazole
6-bromo-7,8-dimethoxy-3-[4-(2-methyl-3-phenylallyl)piperazin-1-ylmethyl]-3a,4-dihydro-3H-chromeno[4,3-c]isoxazole化学式
CAS
——
化学式
C27H32BrN3O4
mdl
——
分子量
542.473
InChiKey
YBUNKZFICCGATE-QGOAFFKASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    35
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    55.8
  • 氢给体数:
    0
  • 氢受体数:
    7

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-bromo-7,8-dimethoxy-3-[4-(2-methyl-3-phenylallyl)piperazin-1-ylmethyl]-3a,4-dihydro-3H-chromeno[4,3-c]isoxazole碳酸二乙酯正丁基锂 作用下, 以 四氢呋喃正己烷 为溶剂, 反应 3.0h, 以8%的产率得到7,8-dimethoxy-3-[4-(2-methyl-3-phenylallyl)piperazin-1-ylmethyl]-3a,4-dihydro-3H-chromeno[4,3-c]isoxazole-6-carboxylic acid ethyl ester
    参考文献:
    名称:
    [EN] C6- AND C9-SUBSTITUTED '4, 3-C! ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTI-DEPRESSANTS
    [FR] DERIVES D'ISOXAZOLINE SUBSTITUES EN C6 ET C9 ET UTILISATION DE CEUX-CI COMME ANTIDEPRESSEURS
    摘要:
    公开号:
    WO2004018482A3
  • 作为产物:
    描述:
    N-(2-methyl-3-phenyl-2(E)-propen-1-yl)piperazine 、 methanesulfonic acid 6-bromo-7,8-dimethoxy-3a,4-dihydro-3H-chromeno[4,3-c]isoxazol-3-ylmethyl ester 在 potassium carbonate 、 potassium iodide 作用下, 以 4-甲基-2-戊酮 为溶剂, 反应 24.0h, 以83%的产率得到6-bromo-7,8-dimethoxy-3-[4-(2-methyl-3-phenylallyl)piperazin-1-ylmethyl]-3a,4-dihydro-3H-chromeno[4,3-c]isoxazole
    参考文献:
    名称:
    [EN] C6- AND C9-SUBSTITUTED '4, 3-C! ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTI-DEPRESSANTS
    [FR] DERIVES D'ISOXAZOLINE SUBSTITUES EN C6 ET C9 ET UTILISATION DE CEUX-CI COMME ANTIDEPRESSEURS
    摘要:
    公开号:
    WO2004018482A3
点击查看最新优质反应信息

文献信息

  • C6- AND C9-SUBSTITUTED CHROMENO[4,3-c]ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTI-DEPRESSANTS
    申请人:Janssen Pharmaceutica NV
    公开号:EP1532155B1
    公开(公告)日:2008-02-27
  • C6- AND C9-SUBSTITUTED CHROMENO[4,3-C]ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTI-DEPRESSANTS
    申请人:JANSSEN PHARMACEUTICA N.V.
    公开号:EP1532155A2
    公开(公告)日:2005-05-25
  • C6-and c9-substituted isoxazoline derivatives and their use as anti-depressants
    申请人:Andres-Gil Ignacio Jose
    公开号:US20060122167A1
    公开(公告)日:2006-06-08
    The invention concerns substituted tricyclic isoxazoline derivatives, more in particular tricyclic dihydrobenzopyranoisoxazoline, dihydroquinolinoisoxazoline, dihydronaphthalenoisoxazoline and dihydrobenzothiopyranoisoxazoline derivatives substituted on at least one of the C6- and C9-positions of the phenylpart of the tricyclic moiety with a selected radical, according to Formula (I) wherein X═CH 2 , N—R 7 , S or O, R 1 , R 2 , R 14 and R 15 are certain specific substituents, with the proviso that at least one of R 14 and R 15 is not hydrogen, Pir is preferably an optionally substituted piperidinyl or piperazinyl radical and R 3 represents an optionally substituted aromatic homocyclic or heterocyclic ring system including a partially or completely hydrogenated hydrocarbon chain of maximum 6 atoms long with which the ring system is attached to the Pir radical and which may contain one or more heteroatoms selected from the group of O, N and S; a process for their preparation, pharmaceutical compositions comprising them and their use as a medicine, in particular for the treatment of depression, anxiety, movement disorders, psychosis, Parkinson's disease and body weight disorders. The compounds according to the invention have surprisingly been shown to have a serotonine (5-HT) reuptake inhibitor activity in combination with additional α 2 -adrenoceptor antagonist activity and show a strong anti-depressant activity without being sedative. The invention also relates to novel combination of isoxazoline derivatives according to the invention with one or more other compounds selected from the group of antidepressants, anxiolytics, anti-psychotics and anti-Parkinson's disease drugs to improve efficacy and/or onset of action.
  • US7462717B2
    申请人:——
    公开号:US7462717B2
    公开(公告)日:2008-12-09
  • [EN] C6- AND C9-SUBSTITUTED '4, 3-C! ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTI-DEPRESSANTS<br/>[FR] DERIVES D'ISOXAZOLINE SUBSTITUES EN C6 ET C9 ET UTILISATION DE CEUX-CI COMME ANTIDEPRESSEURS
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2004018482A3
    公开(公告)日:2004-04-01
查看更多